Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
SEE International, a nonprofit dedicated to providing essential vision care worldwide, is proud to announce the release of a new short film. Entitled “A Mother’s Wish,” the 7-minute documentary tells the emotional story of Nacor, a 7-year old boy living in a tiny village in Peru. Born with cataracts in both eyes, Nacor was already legally blind. If he did not receive treatment soon, he might never see again.
Carmen, the boy’s mother, desperately wished for her sons to see again, but could not afford the vision care that they needed. Thankfully, Carmen heard that SEE would be holding a free clinic in the nearby city of Tarapoto, in July 2017. Thanks to the incredible hard work of the traveling and in-country volunteer surgeons, Nacor received the cataract surgeries that he badly needed. Now he can see normally, participate in school, and play with his friends. He has a bright future ahead of him.
To view the multimedia release go to:
https://www.multivu.com/players/English/8282751-see-international-documentary-a-mothers-wish/
Cancer Treatment Centers of America® (CTCA), a national network of comprehensive cancer care hospitals and outpatient care centers, and Foundation Medicine, a leading molecular insights company that recently received FDA approval for its FoundationOne CDx™ genomic test, today announced the launch of a collaborative educational campaign designed to heighten awareness of the promise of precision medicine and the role that advanced genomic testing plays in helping identify treatments best suited for individual patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8295651-cancer-treatment-centers-of-america-foundation-medicine-precision-cancer-treatment/
Boehringer Ingelheim announced today a new partnership with Minor League Baseball® (MiLB™) to further raise awareness of the rare lung disease idiopathic pulmonary fibrosis (IPF) through its Breathless™ campaign. Now the “Official IPF Awareness Partner of Minor League Baseball,” Boehringer Ingelheim will work with the league to educate its fan base about symptoms of IPF – and the importance of an early diagnosis and treatment – through in-stadium events as well as appearances by New York Yankees legend and musician Bernie Williams, whose father passed away from the disease in 2001.
To view the multimedia release go to:
https://www.multivu.com/players/English/8289951-boehringer-ingelheim-milb-partnership-for-ipf-awareness/
Still searching for the perfect gift to give to a generous dad this Father’s Day? Look no further – Crown Royal is giving dads the royal treatment and enabling you to “Crown Your Father,” this month, creating a unique digital portrait that you can share with dad on social. Now through June 19th, sons, daughters and spouses who are 21+ can visit www.CrownYourFather.com to create a portrait of their dads, husbands or father-like figures as a regal, shareable gift, honoring the generous spirit of fathers everywhere.
Users can choose from five different royal backgrounds, each specially created for the “Crown Your Father” experience, that depict dad in kingly poses – standing atop a cliff next to a lion or relaxing on a throne with a glass of Crown Royal in hand.
To view the multimedia release go to:
https://www.multivu.com/players/English/8116851-crown-royal-fathers-day-crown-your-father/
Solta Medical's novel addition to its aesthetic device solutions, the Clear + Brilliant pélo™ laser, offers personalized results with groundbreaking laser hair removal [LHR] technology to make it fast and simple with minimal pain for anyone to get rid of unwanted hair.
The Clear + Brilliant pélo™ laser provides a highly effective treatment in a short amount of time due to its innovative linear scanning technology and the largest treatment window in the market. A full back takes only 8-12 minutes, and full legs take about 36 minutes. After 5-6 treatments, patients can see the results they want, and still have money in their pocket for the long run.
Each treatment can be customized depending on the individual's needs, and patient comfort is enhanced by minimizing pain on contact through a sapphire glass handpiece that quickly chills to 0°C. So patients and physicians can rest easy that their individual needs are met.
To view the multimedia release go to:
http://www.multivu.com/players/English/7621831-clear-brilliant-pelo-laser-hair-removal/
This Earth Day, sustainability pioneer Fetzer Vineyards announces completion of its revolutionary BIDA® wastewater treatment system, which relies on billions of worms to clean up the winery’s process water. The California vintner’s worms — which work in tandem with microbes to digest contaminants in greywater — are at the heart of a natural system from BioFiltro that uses 85% less energy to clean winery water, regenerating up to 17 million gallons annually for re-use in vineyards and landscaping. The new system is one of a number of Earth-friendly innovations Fetzer Vineyards has recently introduced in an effort to preserve vital resources and find ever-more-efficient ways to put planet conservation on an even playing field with premium winemaking.
To view the multimedia release go to:
https://www.multivu.com/players/English/7990252-fetzer-vineyards-worms-at-work-bida-system/
On the eve of World Cancer Day 2015, amidst the ongoing cost-of-cancer-care debate, PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative, is launching the PACE Continuous Innovation Indicators™ (CII). CII is the first evidence-based, customizable online tool to review progress against cancer over time—initially covering 12 cancer types. The purpose of the tool is to inform public policy reforms and other efforts to accelerate continuous innovation against cancer.
“We have seen tremendous progress in cancer treatment and care during the past decades, and continuous innovation, with one discovery building on another, is responsible for most of it,” said John C. Lechleiter, Ph.D., Chairman, President, and Chief Executive Officer of Eli Lilly and Company (NYSE:LLY). “To keep the momentum going, we need policies that support continuous innovation, but first we need a deeper understanding of the innovations that have occurred, and where we need to be.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7419451-eli-lilly-oncology-pace/
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
One of the most difficult realizations for those with loved ones fighting a serious illness is understanding that treatment is no longer working. No one wants to admit that it has become a losing battle against a serious illness. Many people are hesitant to call hospice for a loved one because they see it as “giving up.” In reality, contacting hospice is a choice that can lead to fewer worries and more meaningful moments during a serious illness or near the end of life.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
